Success Metrics

Clinical Success Rate
100.0%

Based on 24 completed trials

Completion Rate
100%(24/24)
Active Trials
1(3%)
Results Posted
17%(4 trials)

Phase Distribution

Ph early_phase_1
2
7%
Ph phase_1
13
45%
Ph phase_2
3
10%
Ph phase_3
3
10%
Ph not_applicable
2
7%
Ph phase_4
6
21%

Phase Distribution

15

Early Stage

3

Mid Stage

9

Late Stage

Phase Distribution29 total trials
Early Phase 1First-in-human
2(6.9%)
Phase 1Safety & dosage
13(44.8%)
Phase 2Efficacy & side effects
3(10.3%)
Phase 3Large-scale testing
3(10.3%)
Phase 4Post-market surveillance
6(20.7%)
N/ANon-phased studies
2(6.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

24 of 24 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

29

all time

Status Distribution
Active(2)
Completed(24)
Other(3)

Detailed Status

Completed24
unknown3
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
29
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (6.9%)
Phase 113 (44.8%)
Phase 23 (10.3%)
Phase 33 (10.3%)
Phase 46 (20.7%)
N/A2 (6.9%)

Trials by Status

completed2483%
not_yet_recruiting13%
recruiting13%
unknown310%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT00162474Not Applicable

Determinants of Warfarin Metabolism

Recruiting
NCT07531147Phase 4

Effects of Flurbiprofen Spray and Ice Cream for Pain and Voice Outcomes After Thyroidectomy

Not Yet Recruiting
NCT07223671Phase 1

Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

Completed
NCT07235748Phase 1

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Completed
NCT05981365Phase 1

Voxelotor CYP and Transporter Cocktail Interaction Study

Completed
NCT06238154Phase 4

Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds

Completed
NCT05932277Phase 1

A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants

Completed
NCT05852769Phase 1

A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants

Completed
NCT06000137Not Applicable

The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy

Completed
NCT05254548Phase 1

A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects

Completed
NCT04602845Phase 4

Remimazolam Tosilate Sedation and Midazolam Sedation in Dental Patients

Completed
NCT04643249Phase 1

Drug-drug Interaction Study of KL1333 in Healthy Subjects

Completed
NCT04708964Phase 2

Oro-tracheal Intubation: Flurbiprofen Subglottic Instillation to Prevent Laryngeal Inflammation

Unknown
NCT03745599Phase 4

Evaluation of the Effects of Different Analgesics on Pericoronitis Pain and Quality of Life

Completed
NCT00964106Phase 1

Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

Completed
NCT03131973Phase 1

Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin

Completed
NCT01986361Phase 3

Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method

Completed
NCT01048866Phase 3

A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis

Completed
NCT01049334Phase 3

A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis

Completed
NCT00615212Phase 1

Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
29